{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:56:18Z","timestamp":1781646978904,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cientificas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      RNA mis-splicing underlies a growing number of neurological disorders and, consequently, splicing correction therapies have been developed for some monogenic forms, like spinal muscular atrophy or neuronal ceroid lipofuscinosis. In Huntington\u2019s disease (HD), alternative splicing alteration emerged as a molecular mechanism in view of individually reported mis-splicing events in neurodegeneration-linked genes such as\n                      <jats:italic>HTT<\/jats:italic>\n                      itself,\n                      <jats:italic>MAPT<\/jats:italic>\n                      and\n                      <jats:italic>TAF1<\/jats:italic>\n                      . Later, more systematic genome-wide RNA-seq analyses of HD brains revealed mis-splicing signatures involving additional neurodegeneration-linked genes. Individual correction of each of the potentially pathogenic mis-spliced genes would be unapproachable. However, the identification of upstream pivotal splicing factors altered in HD may be useful to design pleiotropic therapeutic strategies. We previously performed motif-enrichment analyses of the sequences flanking exons that are mis-spliced in HD and identified RBFOX splicing factors as underlying candidates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed RT-PCR and Western blot analyses of RBFOX in post-mortem brain samples from HD patients and mice. We generated transgenic mouse lines overexpressing RBFOX1 in forebrain neurons and performed RNA-seq to analyze its impact on HD-associated mis-splicing. In addition, we combined HD mice with RBFOX1-overexpressing mice to verify correction of Rbfox1 levels and mis-splicing of RBFOX target genes, and performed histopathological and motor behavioral analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed that decreased expression of Rbfox1 in striatum of HD mice at early stages of disease progression correlates with a reduction of Rbfox1 immunostaining particularly in the nucleus. This prompted us to generate transgenic mouse lines overexpressing the nuclear isoform of RBFOX1. The overexpression of RBFOX1 in this new transgenic mouse line induced widespread alternative splicing changes that significantly overlapped with genes mis-spliced in brains of both HD patients and mouse models. We found that moderate neuronal RBFOX1 overexpression in HD mice results in correction of several HD-associated mis-splicing events and in attenuation of neurodegeneration and motor symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results demonstrate that the observed decrease of RBFOX1 levels in brains of HD patients and mice contributes to HD pathogenesis and suggest therapeutic potential of RBFOX-increasing strategies for HD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-026-01471-y","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:27:27Z","timestamp":1775104047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modest rescue of RBFOX1 splicing function attenuates Huntington\u2019s disease features"],"prefix":"10.1186","volume":"32","author":[{"given":"David","family":"Lozano-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainara","family":"Elorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Lucas-Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Santos-Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Parras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 J.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"1471_CR10","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Primers. 2015;1:15005.","journal-title":"Nat Rev Dis Primers"},{"key":"1471_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/B978-0-12-418700-9.00008-3","volume":"113","author":"BR Bill","year":"2013","unstructured":"Bill BR, Lowe JK, Dybuncio CT, Fogel BL. Orchestration of neurodevelopmental programs by RBFOX1: implications for autism spectrum disorder. Int Rev Neurobiol. 2013;113:251\u201367.","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"1471_CR44","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/s41467-018-04892-4","volume":"9","author":"E Cerro-Herreros","year":"2018","unstructured":"Cerro-Herreros E, Sabater-Arcis M, Fernandez-Costa JM, Moreno N, Perez-Alonso M, Llamusi B, et al. miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models. Nat Commun. 2018;9(1):2482.","journal-title":"Nat Commun"},{"issue":"2","key":"1471_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1261\/rna.1838210","volume":"16","author":"A Damianov","year":"2010","unstructured":"Damianov A, Black DL. Autoregulation of Fox protein expression to produce dominant negative splicing factors. RNA. 2010;16(2):405\u201316.","journal-title":"RNA"},{"issue":"10","key":"1471_CR20","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/mds.28287","volume":"35","author":"SH Diaw","year":"2020","unstructured":"Diaw SH, Lohmann K. Linking Huntington\u2019s Disease and X-linked Dystonia Parkinsonism on the Molecular Level. Mov Disord. 2020;35(10):1752\u20133.","journal-title":"Mov Disord"},{"issue":"1","key":"1471_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"7","key":"1471_CR7","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/brain\/awab087","volume":"144","author":"A Elorza","year":"2021","unstructured":"Elorza A, Marquez Y, Cabrera JR, Sanchez-Trincado JL, Santos-Galindo M, Hernandez IH, et al. Huntington\u2019s disease-specific mis-splicing unveils key effector genes and altered splicing factors. Brain. 2021;144(7):2009\u201323.","journal-title":"Brain"},{"issue":"8","key":"1471_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nm.3617","volume":"20","author":"M Fernandez-Nogales","year":"2014","unstructured":"Fernandez-Nogales M, Cabrera JR, Santos-Galindo M, Hoozemans JJ, Ferrer I, Rozemuller AJ, et al. Huntington\u2019s disease is a four-repeat tauopathy with tau nuclear rods. Nat Med. 2014;20(8):881\u20135.","journal-title":"Nat Med"},{"key":"1471_CR4","doi-asserted-by":"crossref","unstructured":"Fratta P, Sivakumar P, Humphrey J, Lo K, Ricketts T, Oliveira H et al. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J. 2018;37:e98684.","DOI":"10.15252\/embj.201798684"},{"key":"1471_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.gde.2020.03.007","volume":"65","author":"T Gonatopoulos-Pournatzis","year":"2020","unstructured":"Gonatopoulos-Pournatzis T, Blencowe BJ. Microexons: at the nexus of nervous system development, behaviour and autism spectrum disorder. Curr Opin Genet Dev. 2020;65:22\u201333.","journal-title":"Curr Opin Genet Dev"},{"issue":"6","key":"1471_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"HDCRG HsDCRG","year":"1993","unstructured":"HDCRG HsDCRG. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72(6):971\u201383.","journal-title":"Cell"},{"issue":"7","key":"1471_CR18","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/brain\/awaa150","volume":"143","author":"IH Hernandez","year":"2020","unstructured":"Hernandez IH, Cabrera JR, Santos-Galindo M, Sanchez-Martin M, Dominguez V, Garcia-Escudero R, et al. Pathogenic SREK1 decrease in Huntington\u2019s disease lowers TAF1 mimicking X-linked dystonia parkinsonism. Brain. 2020;143(7):2207\u201319.","journal-title":"Brain"},{"issue":"1","key":"1471_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2005.01.024","volume":"20","author":"MA Hickey","year":"2005","unstructured":"Hickey MA, Gallant K, Gross GG, Levine MS, Chesselet MF. Early behavioral deficits in R6\/2 mice suitable for use in preclinical drug testing. Neurobiol Dis. 2005;20(1):1\u201311.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1471_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.celrep.2019.08.104","volume":"29","author":"YC Hsieh","year":"2019","unstructured":"Hsieh YC, Guo C, Yalamanchili HK, Abreha M, Al-Ouran R, Li Y, et al. Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer\u2019s Disease. Cell Rep. 2019;29(2):301\u201316. e10.","journal-title":"Cell Rep"},{"issue":"7","key":"1471_CR49","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.cell.2014.11.035","volume":"159","author":"M Irimia","year":"2014","unstructured":"Irimia M, Weatheritt RJ, Ellis JD, Parikshak NN, Gonatopoulos-Pournatzis T, Babor M, et al. A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell. 2014;159(7):1511\u201323.","journal-title":"Cell"},{"key":"1471_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-cellbio-101011-155831","volume":"30","author":"M Ivshina","year":"2014","unstructured":"Ivshina M, Lasko P, Richter JD. Cytoplasmic polyadenylation element binding proteins in development, health, and disease. Annu Rev Cell Dev Biol. 2014;30:393\u2013415.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"10","key":"1471_CR42","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1534\/g3.117.300232","volume":"7","author":"P Katti","year":"2017","unstructured":"Katti P, Thimmaya D, Madan A, Nongthomba U. Overexpression of miRNA-9 Generates Muscle Hypercontraction Through Translational Repression of Troponin-T in Drosophila melanogaster Indirect Flight Muscles. G3 (Bethesda). 2017;7(10):3521\u201331.","journal-title":"G3 (Bethesda)"},{"issue":"45","key":"1471_CR23","doi-asserted-by":"publisher","first-page":"31052","DOI":"10.1074\/jbc.M109.052969","volume":"284","author":"KK Kim","year":"2009","unstructured":"Kim KK, Adelstein RS, Kawamoto S. Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors. J Biol Chem. 2009;284(45):31052\u201361.","journal-title":"J Biol Chem"},{"issue":"1","key":"1471_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41467-017-02757-w","volume":"9","author":"MM Kucherenko","year":"2018","unstructured":"Kucherenko MM, Shcherbata HR. Stress-dependent miR-980 regulation of Rbfox1\/A2bp1 promotes ribonucleoprotein granule formation and cell survival. Nat Commun. 2018;9(1):312.","journal-title":"Nat Commun"},{"issue":"24","key":"1471_CR22","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1007\/s00018-009-0120-5","volume":"66","author":"H Kuroyanagi","year":"2009","unstructured":"Kuroyanagi H. Fox-1 family of RNA-binding proteins. Cell Mol Life Sci. 2009;66(24):3895\u2013907.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1471_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuron.2015.11.025","volume":"89","author":"JA Lee","year":"2016","unstructured":"Lee JA, Damianov A, Lin CH, Fontes M, Parikshak NN, Anderson ES, et al. Cytoplasmic Rbfox1 Regulates the Expression of Synaptic and Autism-Related Genes. Neuron. 2016;89(1):113\u201328.","journal-title":"Neuron"},{"issue":"19","key":"1471_CR29","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1101\/gad.1837009","volume":"23","author":"JA Lee","year":"2009","unstructured":"Lee JA, Tang ZZ, Black DL. An inducible change in Fox-1\/A2BP1 splicing modulates the alternative splicing of downstream neuronal target exons. Genes Dev. 2009;23(19):2284\u201393.","journal-title":"Genes Dev"},{"issue":"7198","key":"1471_CR12","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/nature06909","volume":"453","author":"LB Li","year":"2008","unstructured":"Li LB, Yu Z, Teng X, Bonini NM. RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature. 2008;453(7198):1107\u201311.","journal-title":"Nature"},{"issue":"11","key":"1471_CR47","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.celrep.2016.05.022","volume":"15","author":"L Lin","year":"2016","unstructured":"Lin L, Goke J, Cukuroglu E, Dranias MR, VanDongen AM, Stanton LW. Molecular Features Underlying Neurodegeneration Identified through In Vitro Modeling of Genetically Diverse Parkinson\u2019s Disease Patients. Cell Rep. 2016;15(11):2411\u201326.","journal-title":"Cell Rep"},{"issue":"16","key":"1471_CR5","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1093\/hmg\/ddw187","volume":"25","author":"L Lin","year":"2016","unstructured":"Lin L, Park JW, Ramachandran S, Zhang Y, Tseng YT, Shen S, et al. Transcriptome sequencing reveals aberrant alternative splicing in Huntington\u2019s disease. Hum Mol Genet. 2016;25(16):3454\u201366.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1471_CR3","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1038\/s41467-018-04373-8","volume":"9","author":"R Luisier","year":"2018","unstructured":"Luisier R, Tyzack GE, Hall CE, Mitchell JS, Devine H, Taha DM, et al. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat Commun. 2018;9(1):2010.","journal-title":"Nat Commun"},{"issue":"3","key":"1471_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1086\/512129","volume":"80","author":"S Makino","year":"2007","unstructured":"Makino S, Kaji R, Ando S, Tomizawa M, Yasuno K, Goto S, et al. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet. 2007;80(3):393\u2013406.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1471_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ng0297-197","volume":"15","author":"L Mangiarini","year":"1997","unstructured":"Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP. Instability of highly expanded CAG repeats in mice transgenic for the Huntington\u2019s disease mutation. Nat Genet. 1997;15(2):197\u2013200.","journal-title":"Nat Genet"},{"issue":"5293","key":"1471_CR25","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1126\/science.274.5293.1678","volume":"274","author":"M Mayford","year":"1996","unstructured":"Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER. Control of memory formation through regulated expression of a CaMKII transgene. Science. 1996;274(5293):1678\u201383.","journal-title":"Science"},{"key":"1471_CR35","unstructured":"Menalled L, Cat L, Ramboz S, Brunner D, Lager B, Noble S et al. A field guide to working with mouse models of Huntington\u2019s disease. 2014. https:\/\/chdifoundation.org\/wp-content\/uploads\/HD_Field_Guide_040414.pdf."},{"issue":"1","key":"1471_CR48","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1038\/s41467-023-39936-x","volume":"14","author":"M Mullari","year":"2023","unstructured":"Mullari M, Fossat N, Skotte NH, Asenjo-Martinez A, Humphreys DT, Bukh J, et al. Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington\u2019s disease. Nat Commun. 2023;14(1):4348.","journal-title":"Nat Commun"},{"issue":"20","key":"1471_CR14","doi-asserted-by":"publisher","first-page":"8938","DOI":"10.1093\/nar\/gkr608","volume":"39","author":"A Mykowska","year":"2011","unstructured":"Mykowska A, Sobczak K, Wojciechowska M, Kozlowski P, Krzyzosiak WJ. CAG repeats mimic CUG repeats in the misregulation of alternative splicing. Nucleic Acids Res. 2011;39(20):8938\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"1471_CR30","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/nar\/gki338","volume":"33","author":"S Nakahata","year":"2005","unstructured":"Nakahata S, Kawamoto S. Tissue-dependent isoforms of mammalian Fox-1 homologs are associated with tissue-specific splicing activities. Nucleic Acids Res. 2005;33(7):2078\u201389.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1471_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.biopsych.2023.03.010","volume":"94","author":"I Olla","year":"2023","unstructured":"Olla I, Pardinas AF, Parras A, Hernandez IH, Santos-Galindo M, Pico S, et al. Pathogenic Mis-splicing of CPEB4 in Schizophrenia. Biol Psychiatry. 2023;94(4):341\u201351.","journal-title":"Biol Psychiatry"},{"key":"1471_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007;30:575\u2013621.","journal-title":"Annu Rev Neurosci"},{"issue":"7719","key":"1471_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41586-018-0423-5","volume":"560","author":"A Parras","year":"2018","unstructured":"Parras A, Anta H, Santos-Galindo M, Swarup V, Elorza A, Nieto-Gonzalez JL, et al. Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing. Nature. 2018;560(7719):441\u20136.","journal-title":"Nature"},{"issue":"613","key":"1471_CR38","doi-asserted-by":"publisher","first-page":"eabe7104","DOI":"10.1126\/scitranslmed.abe7104","volume":"13","author":"S Pic\u00f3","year":"2021","unstructured":"Pic\u00f3 S, Parras A, Santos-Galindo M, Pose-Utrilla J, Castro M, Fraga E, et al. CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington\u2019s disease. Sci Transl Med. 2021;13(613):eabe7104.","journal-title":"Sci Transl Med"},{"issue":"12","key":"1471_CR41","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.15252\/embj.201695748","volume":"36","author":"M Rajman","year":"2017","unstructured":"Rajman M, Metge F, Fiore R, Khudayberdiev S, Aksoy-Aksel A, Bicker S, et al. A microRNA-129-5p\/Rbfox crosstalk coordinates homeostatic downscaling of excitatory synapses. EMBO J. 2017;36(12):1770\u201387.","journal-title":"EMBO J"},{"issue":"11","key":"1471_CR1","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41588-018-0238-1","volume":"50","author":"T Raj","year":"2018","unstructured":"Raj T, Li YI, Wong G, Humphrey J, Wang M, Ramdhani S, et al. Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer\u2019s disease susceptibility. Nat Genet. 2018;50(11):1584\u201392.","journal-title":"Nat Genet"},{"key":"1471_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev.neuro.29.051605.113014","volume":"29","author":"LP Ranum","year":"2006","unstructured":"Ranum LP, Cooper TA. RNA-mediated neuromuscular disorders. Annu Rev Neurosci. 2006;29:259\u201377.","journal-title":"Annu Rev Neurosci"},{"issue":"6","key":"1471_CR16","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam K, Neueder A, Gipson TA, Landles C, Benjamin AC, Bondulich MK, et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A. 2013;110(6):2366\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1471_CR6","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.jmb.2019.01.034","volume":"431","author":"J Schilling","year":"2019","unstructured":"Schilling J, Broemer M, Atanassov I, Duernberger Y, Vorberg I, Dieterich C, et al. Deregulated Splicing Is a Major Mechanism of RNA-Induced Toxicity in Huntington\u2019s Disease. J Mol Biol. 2019;431(9):1869\u201377.","journal-title":"J Mol Biol"},{"issue":"1","key":"1471_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.celrep.2018.06.017","volume":"24","author":"RK Singh","year":"2018","unstructured":"Singh RK, Kolonin AM, Fiorotto ML, Cooper TA. Rbfox-Splicing Factors Maintain Skeletal Muscle Mass by Regulating Calpain3 and Proteostasis. Cell Rep. 2018;24(1):197\u2013208.","journal-title":"Cell Rep"},{"issue":"2","key":"1471_CR37","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41380-021-01151-9","volume":"27","author":"J Sitbon","year":"2022","unstructured":"Sitbon J, Nestvogel D, Kappeler C, Nicolas A, Maciuba S, Henrion A, et al. CADPS functional mutations in patients with bipolar disorder increase the sensitivity to stress. Mol Psychiatry. 2022;27(2):1145\u201357.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1471_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-907X-3-1","volume":"3","author":"J Stenvang","year":"2012","unstructured":"Stenvang J, Petri A, Lindow M, Obad S, Kauppinen S. Inhibition of microRNA function by antimiR oligonucleotides. Silence. 2012;3(1):1.","journal-title":"Silence"},{"issue":"19","key":"1471_CR15","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1093\/hmg\/ddr297","volume":"20","author":"H Tsoi","year":"2011","unstructured":"Tsoi H, Lau CK, Lau KF, Chan HY. Perturbation of U2AF65\/NXF1-mediated RNA nuclear export enhances RNA toxicity in polyQ diseases. Hum Mol Genet. 2011;20(19):3787\u201397.","journal-title":"Hum Mol Genet"},{"issue":"9557","key":"1471_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Lancet. 2007;369(9557):218\u201328.","journal-title":"Lancet"},{"issue":"6","key":"1471_CR27","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.celrep.2014.02.005","volume":"6","author":"SM Weyn-Vanhentenryck","year":"2014","unstructured":"Weyn-Vanhentenryck SM, Mele A, Yan Q, Sun S, Farny N, Zhang Z, et al. HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism. Cell Rep. 2014;6(6):1139\u201352.","journal-title":"Cell Rep"},{"issue":"2","key":"1471_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tins.2021.10.009","volume":"45","author":"Y Xing","year":"2021","unstructured":"Xing Y, Wang R, Davidson BL. Mis-splicing in Huntington\u2019s disease: harnessing the power of comparative transcriptomics. Trends Neurosci. 2021;45(2):91\u20133.","journal-title":"Trends Neurosci"},{"key":"1471_CR46","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fphys.2014.00380","volume":"5","author":"D Zielonka","year":"2014","unstructured":"Zielonka D, Piotrowska I, Marcinkowski JT, Mielcarek M. Skeletal muscle pathology in Huntington\u2019s disease. Front Physiol. 2014;5:380.","journal-title":"Front Physiol"},{"issue":"3","key":"1471_CR51","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E. Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev. 2010;90(3):905\u201381.","journal-title":"Physiol Rev"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01471-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01471-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01471-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:22:15Z","timestamp":1781644935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01471-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1471"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01471-y","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}